Exited company
Cytochroma Inc.
Lead
![Ela Borenstein - Vice president, venture capital at BDC]()
About the company
Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).